Biofrontera Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.018 million compared to USD 0.015 million a year ago. Revenue was USD 8.73 million compared to USD 9.75 million a year ago.

Net loss was USD 7.48 million compared to net income of USD 5.56 million a year ago. Basic loss per share from continuing operations was USD 5.6 compared to basic earnings per share from continuing operations of USD 6.6 a year ago. Diluted loss per share from continuing operations was USD 5.6 compared to diluted earnings per share from continuing operations of USD 6.4 a year ago.